Sequencing of nucleic acids via barcoding in discrete entities

US11732287B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11732287-B2
Application numberUS-201815940850-A
CountryUS
Kind codeB2
Filing dateMar 29, 2018
Priority dateFeb 4, 2015
Publication dateAug 22, 2023
Grant dateAug 22, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Microfluidic methods for barcoding nucleic acid target molecules to be analyzed, e.g., via nucleic acid sequencing techniques, are provided. Also provided are microfluidic, droplet-based methods of preparing nucleic acid barcodes for use in various barcoding applications. The methods described herein facilitate high-throughput sequencing of nucleic acid target molecules as well as single cell and single virus genomic, transcriptomic, and/or proteomic analysis/profiling. Systems and devices for practicing the subject methods are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for detecting target molecules, the method comprising: providing a plurality of affinity reagents to a single cell under conditions sufficient for binding of one of the plurality of affinity reagents to a molecular target of the single cell to form an affinity reagent bound molecular target, the affinity reagent bound to the molecular target having an oligonucleotide including a first nucleic acid barcode, wherein the first nucleic acid barcode serves as an indicator of the affinity reagent binding to the molecular target; purifying the single cell by removing unbound affinity reagents of the plurality; encapsulating the single cell with the affinity reagent bound molecular target comprising the oligonucleotide including the first nucleic acid barcode in a discrete entity; lysing the single cell within the discrete entity such that the discrete entity comprises a released nucleic acid from within the single cell and the oligonucleotide including the first nucleic acid barcode; subsequent to lysing the single cell, encapsulating, with the oligonucleotide including the first nucleic acid barcode and the released nucleic acid from within the single cell or a product of the released nucleic acid, a plurality of primer sequences, a plurality of copies of a sequence comprising both a second nucleic acid barcode and a universal sequence, wherein the second nucleic acid barcode serves as an indicator of the discrete entity in which the oligonucleotide including the first nucleic acid barcode and the released nucleic acid are encapsulated; incorporating a first copy of the sequence comprising the second nucleic acid barcode and the universal sequence with the oligonucleotide including the first nucleic acid barcode by performing nucleic acid amplification using the universal sequence of the first copy and at least a first primer sequence; incorporating a second copy of the sequence comprising the second nucleic acid barcode and the universal sequence with the released nucleic acid or the product of the released nucleic acid by performing nucleic acid amplification using the universal sequence of the second copy and at least a second primer sequence; and sequencing the first nucleic acid barcode, the first copy of the sequence comprising the second nucleic acid barcode, and the second copy of the sequence comprising the second nucleic acid barcode. 2. The method of claim 1 , wherein the affinity reagent comprises a peptide. 3. The method of claim 1 , wherein the affinity reagent comprises an antibody or an antigen binding antibody fragment. 4. The method of claim 1 , wherein the affinity reagent does not comprise an antibody. 5. The method of claim 1 , wherein the affinity reagent comprises a drug. 6. The method of claim 1 , wherein the molecular target is a component of a cell. 7. The method of claim 1 , wherein the product of the released nucleic acid is generated by performing reverse transcription on the released nucleic acid. 8. The method of claim 7 , wherein the reverse transcription occurs without nucleic acid amplification. 9. The method of claim 7 , wherein the product of the released nucleic acid is further generated by performing nucleic acid amplification. 10. The method of claim 9 , comprising sequencing the amplification product. 11. The method of claim 7 , wherein the product of the released nucleic acid is generated by performing nucleic acid amplification after performing reverse transcription. 12. The method of claim 7 , wherein the product of the released nucleic acid is generated by performing reverse transcription on the released nucleic acid to produce a reverse transcription product and amplifying the reverse transcription product, wherein performing reverse transcription and amplifying occur in a single step. 13. The method of claim 7 , further comprising sequencing the reverse transcription product. 14. The method of claim 1 , comprising amplifying the oligonucleotide before incorporating the second nucleic acid barcode. 15. The method of claim 1 , wherein the incorporating comprises linking the first nucleic acid barcode and the first copy of the second nucleic acid barcode to produce a composite nucleic acid barcode molecule. 16. A method for detecting target molecules, the method comprising: providing a plurality of affinity reagents to a single cell under conditions sufficient for binding of one of the plurality of affinity reagents to a molecular target of the single cell to form an affinity reagent bound molecular target, the affinity reagent bound to the molecular target having an oligonucleotide including a first nucleic acid barcode, wherein the first nucleic acid barcode serves as an indicator of the affinity reagent binding to the molecular target; purifying the single cell by removing unbound affinity reagents of the plurality; encapsulating the single cell with the affinity reagent bound molecular target comprising the oligonucleotide including the first nucleic acid barcode in a discrete entity; lysing the single cell within the discrete entity such that the discrete entity comprises a RNA molecule from within the single cell, a DNA molecule from within the single cell, and the oligonucleotide including the first nucleic acid barcode, wherein the lysing comprises digesting cellular proteins of the single cell using a proteinase K; subsequent to lysing the single cell, encapsulating, with the oligonucleotide including the first nucleic acid barcode, a cDNA molecule derived from the RNA molecule from within the single cell, and the DNA molecule from within the single cell, a plurality of primer sequences, a plurality of copies of a sequence comprising both a second nucleic acid barcode and a universal sequence, wherein the second nucleic acid barcode serves as an indicator of the discrete entity; incorporating a first copy of the sequence comprising the second nucleic acid barcode and the universal sequence with the oligonucleotide including the first nucleic acid barcode by performing nucleic acid amplification using the universal sequence of the first copy and at least a first primer sequence; incorporating a second copy of the sequence comprising the second nucleic acid barcode and the universal sequence with the cDNA molecule derived from the RNA molecule y, performing nucleic acid amplification using the universal sequence of the second copy and at least a second primer sequence; incorporating a third copy of the sequence comprising the second nucleic acid barcode and the universal sequence with the DNA molecule by performing nucleic acid amplification using the universal sequence of the third copy and at least a third primer sequence; and sequencing the first nucleic acid barcode, the first copy of the sequence comprising the second nucleic acid barcode, the second copy of the sequence comprising the second nucleic acid barcode, and the third copy of the sequence comprising the second nucleic acid barcode. 17. A method for detecting target molecules, the method comprising: providing a plurality of affinity reagents to a single cell under conditions sufficient for binding of one of the plurality of affinity reagents to a molecular target of the single cell to form an affinity reagent bound molecular target, the affinity reagent bound to the molecular target having an oligonucleotide including a first nucleic acid barcode, wherein the first nucleic acid barcode serves as an indicator of the affinity reagent binding to the molecular target; purifying the single cell by removing unbound affinity reagents of th

Assignees

Inventors

Classifications

  • specially adapted for sorting particles, e.g. by their size or optical properties · CPC title

  • C12Q1/6804Primary

    Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

  • Mixers with a succession of converging-diverging cross-sections, i.e. undulating cross-section · CPC title

  • the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets · CPC title

  • specially adapted for droplet or plug flow, e.g. digital microfluidics · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11732287B2 cover?
Microfluidic methods for barcoding nucleic acid target molecules to be analyzed, e.g., via nucleic acid sequencing techniques, are provided. Also provided are microfluidic, droplet-based methods of preparing nucleic acid barcodes for use in various barcoding applications. The methods described herein facilitate high-throughput sequencing of nucleic acid target molecules as well as single cell a…
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C12Q1/6804. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).